Covered recipient · General Payments record
BEATA HOLKOVA
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018
$4,347.34
- Reported across 10 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $2,640.00 | 1 |
| Travel and Lodging | $1,648.10 | 6 |
| Food and Beverage | $34.66 | 1 |
| Education | $24.58 | 2 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $2,640.00 | 1 |
| GlaxoSmithKline, LLC. | $1,682.76 | 7 |
| SEAGEN INC. | $24.58 | 2 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $4,347.34 | 10 |
Payment records · PY2018 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Celgene Corporation | $2,640.00 | 06/12/2018 | Consulting Fee | Undisputed | 01/23/2026 | 595300833 | CMS |
| GlaxoSmithKline, LLC. | $185.90 | 10/30/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 596736545 | CMS |
| GlaxoSmithKline, LLC. | $564.90 | 10/30/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 596736553 | CMS |
| GlaxoSmithKline, LLC. | $97.75 | 10/30/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 596736563 | CMS |
| GlaxoSmithKline, LLC. | $34.66 | 10/31/2018 | Food and Beverage | Undisputed | 01/23/2026 | 596330631 | CMS |
| GlaxoSmithKline, LLC. | $515.90 | 10/31/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 596738725 | CMS |
| GlaxoSmithKline, LLC. | $185.90 | 10/31/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 596790609 | CMS |
| GlaxoSmithKline, LLC. | $97.75 | 10/31/2018 | Travel and Lodging | Undisputed | 01/23/2026 | 596793072 | CMS |
| Seattle Genetics, Inc. | $12.29 | 05/11/2018 | Education | Undisputed | 01/23/2026 | 607623281 | CMS |
| Seattle Genetics, Inc. | $12.29 | 06/14/2018 | Education | Undisputed | 01/23/2026 | 607623981 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.